Biosig Technologies, Common Stock Profit Margin
| BSGM Stock | USD 1.10 0.32 22.54% |
BioSig Technologies, Common fundamentals help investors to digest information that contributes to BioSig Technologies,'s financial success or failures. It also enables traders to predict the movement of BioSig OTC Stock. The fundamental analysis module provides a way to measure BioSig Technologies,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BioSig Technologies, otc stock.
BioSig |
BioSig Technologies, Common OTC Stock Profit Margin Analysis
BioSig Technologies,'s Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, BioSig Technologies, Common has a Profit Margin of 0.0%. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The profit margin for all United States stocks is 100.0% lower than that of the firm.
BioSig Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BioSig Technologies,'s direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of BioSig Technologies, could also be used in its relative valuation, which is a method of valuing BioSig Technologies, by comparing valuation metrics of similar companies.BioSig Technologies, is currently under evaluation in profit margin category among its peers.
BioSig Fundamentals
| Return On Equity | -59.77 | ||||
| Return On Asset | -4.48 | ||||
| Operating Margin | (227.43) % | ||||
| Current Valuation | 6.43 M | ||||
| Shares Outstanding | 14.12 M | ||||
| Shares Owned By Insiders | 17.59 % | ||||
| Shares Owned By Institutions | 3.04 % | ||||
| Number Of Shares Shorted | 461.7 K | ||||
| Price To Earning | (3.73) X | ||||
| Price To Book | 36.58 X | ||||
| Price To Sales | 90.04 X | ||||
| Revenue | 18 K | ||||
| Gross Profit | 242 K | ||||
| EBITDA | (28.15 M) | ||||
| Net Income | (28.69 M) | ||||
| Cash And Equivalents | 887 K | ||||
| Cash Per Share | 0.02 X | ||||
| Total Debt | 452 K | ||||
| Debt To Equity | 0.45 % | ||||
| Current Ratio | 1.22 X | ||||
| Book Value Per Share | (0.39) X | ||||
| Cash Flow From Operations | (17.31 M) | ||||
| Short Ratio | 0.95 X | ||||
| Earnings Per Share | (0.86) X | ||||
| Target Price | 6.0 | ||||
| Beta | 0.84 | ||||
| Market Capitalization | 6.64 M | ||||
| Total Asset | 1.8 M | ||||
| Retained Earnings | (245.01 M) | ||||
| Working Capital | (4.05 M) | ||||
| Current Asset | 984.54 K | ||||
| Current Liabilities | 2.47 M | ||||
| Net Asset | 1.8 M |
About BioSig Technologies, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BioSig Technologies, Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioSig Technologies, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioSig Technologies, Common based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in BioSig OTC Stock
BioSig Technologies, financial ratios help investors to determine whether BioSig OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioSig with respect to the benefits of owning BioSig Technologies, security.